Orthocell Ltd (AU:OCC) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Orthocell Ltd (ASX: OCC) has requested a trading halt on its securities pending an important announcement regarding the regulatory study results necessary for FDA market approval of its product, Remplir, in the US. This strategic pause aims to manage market expectations and ensure investors are well-informed. The halt will remain effective until the announcement is made or until normal trading resumes on December 3, 2024.
For further insights into AU:OCC stock, check out TipRanks’ Stock Analysis page.